CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 35 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04638920
NCT04638920N/ACompleted
CompareCT.gov

Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy (TripleEX)

Malcolm Kohler·observational·Posted Nov 20, 2020·Updated Apr 2, 2025

In Brief

An observational study evaluating No intervention for COPD Exacerbation. Completed, enrolled 35 participants across 1 site.

Detailed Summary

Determination of specific molecular breath patterns by secondary electrospray ionization mass spectrometry (SESIHRMS) during and 8 weeks after a COPD exacerbation. Furthermore, breath patterns will be assessed for correlation and association with clinical outcomes and treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOPD Exacerbation
CountriesSwitzerland
CollaboratorsDeep Breath Intelligence (DBI)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 20, 2020
Enrollment StartNov 16, 2020
Primary CompletionApr 30, 2024
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 5.6 years ago

Interventions

No interventionother

No intervention